Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan/Amlodipine FDC in Moderate to Severe Hypertension
NCT01204398Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2010
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of telmisartan, amlodipine in hypertension (HTN), sponsored by Boehringer Ingelheim. Started Nov 2010; status: completed.
02
Drugs
telmisartanamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01204398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01204398.